Thyroid hormone controls the gene expression of HSV-1 LAT and ICP0 in neuronal cells

Cell Research

Volumn 20, Issue 5, 2010, Pages 587-598

  Bedadala, Gautam R ^a   Pinnoji, Rajeswara C ^a   Palem, Jayavardhana R ^a   Hsia, Shao Chung V ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

Chromatin; HSV 1; ICP0; LAT; Latency; Thyroid hormone; Transcription

Indexed keywords

LATENCY ASSOCIATED TRANSCRIPT, HERPES SIMPLEX VIRUS 1; LATENCY ASSOCIATED TRANSCRIPT, HERPES SIMPLEX VIRUS-1; LIOTHYRONINE; MICRORNA; THYROID HORMONE RECEPTOR;

ANIMAL; ARTICLE; CHROMATIN; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; METABOLISM; MOLECULAR GENETICS; NERVE CELL; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE; VIROLOGY;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CHROMATIN; GENE EXPRESSION REGULATION, VIRAL; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; MICRORNAS; MOLECULAR SEQUENCE DATA; NEURONS; RECEPTORS, THYROID HORMONE; TRANSCRIPTION, GENETIC; TRIIODOTHYRONINE;

HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 77952089952     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2010.50     Document Type: Article

References (52)

1. Goldenberg D, Mador N, Ball MJ, Panet A, Steiner I. The abundant latency-associated transcripts of herpes simplex virus type 1 are bound to polyribosomes in cultured neuronal cells and during latent infection in mouse trigeminal ganglia. J Virol 1997;71:2897-2904. (Pubitemid 27119931)
2. Javier RT, Stevens JG, Dissette VB, Wagner EK. A herpes simplex virus transcript abundant in latently infected neurons is dispensable for establishment of the latent state. Virology 1988;166:254-257.
3. Jones C. Herpes simplex virus type 1 and bovine herpesvirus 1 latency. Clin Microbiol Rev 2003;16:79-95. (Pubitemid 36114708)
4. Wu TT, su YH, Block TM, Taylor JM. Evidence that two latency-associated transcripts of herpes simplex virus type 1 are nonlinear. J Virol 1996;70:5962-5967.
5. Cook ML, Thompson RL, Stevens JG. A herpes simplex virus mutant is temperature sensitive for reactivation from the latent state: evidence for selective restriction in neuronal cells. Virology 1986;155:293-296.
6. Ecob-Prince M, Hassan K. Reactivation of latent herpes simplex virus from explanted dorsal root ganglia. J Gen Virol 1994; J Gen Virol 1994; (Pt 8) : 2017-2028. (Pubitemid 24243083)
7. Kriesel JD, Ricigliano J, Spruance SL, Garza HH Jr, Hill JM. Neuronal reactivation of herpes simplex virus may involve interleukin-6. J Neurovirol 1997;3:441-448. (Pubitemid 28041144)
8. Sawtell NM, Thompson RL. Comparison of herpes simplex virus reactivation in ganglia in vivo and in explants demonstrates quantitative and qualitative differences. J Virol 2004;78:7784-7794.
9. Koelle DM, Corey L. Herpes simplex: insights on pathogenesis and possible vaccines. Annu Rev Med 2008;59:381-395. (Pubitemid 351287944)
10. Vider-Shalit T, Fishbain V, Raffaeli S, Louzoun Y. Phasedependent immune evasion of herpesviruses. J Virol 2007;81:9536-9545.
11. Bystricka M, Russ G. Immunity in latent herpes simplex virus infection. Acta Virol 2005;49:159-167.
12. Morrison LA, Knipe DM. Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1. Vi - rology 1996;220:402-413. (Pubitemid 126335624)
13. Cui C, Griffths A, Li G, et al. Prediction and identifcation of herpes simplex virus 1-encoded microRNAs. J Virol 2006;80:5499-5508. (Pubitemid 43752795)
14. Block T, Barney S, Masonis J, et al. Long term herpes simplex virus type 1 infection of nerve growth factor-treated PC12 cells. J Gen Virol 1994; J Gen Virol 1994; (Pt 9) : 2481-2487. (Pubitemid 24282269)
15. Moxley MJ, Block TM, Liu HC, et al. Herpes simplex virus type 1 infection prevents detachment of nerve growth factordifferentiated PC12 cells in culture. J Gen Virol 2002; J Gen Virol 2002; (Pt 7) : 1591-1600.
16. su YH, Moxley M, Kejariwal R, et al. The HSV The HSVgenome in quiescently infected NGF differentiated PC12 cells cannot be stimulated by HSV superinfection. J Neurovirol 2000;6:341-349
17. su YH, Moxley MJ, Ng AK, et al. Stability and circularization of herpes simplex virus type 1 genomes in quiescently infected PC12 cultures. J Gen Virol 2002; J Gen Virol 2002; (Pt 12) :2943-2950.
18. Garza HH Jr, Hill JM. Effect of a beta-adrenergic antagonist, propranolol, on induced HSV-1 ocular recurrence in latently infected rabbits. Curr Eye Res 1997;16:453-458.
19. Hardwicke MA, Schaffer PA. Differential effects of nerve growth factor and dexamethasone on herpes simplex virus type 1 oriL-and oriS-dependent DNA replication in PC12 cells. J Virol 1997;71:3580-3587.
20. Marquart M, Bhattacharjee P, Zheng X, et al. Ocular reactivation phenotype of HSV-1 strain F (MP) E, a corticosteroidsensitive strain. Curr Eye Res 2003;26:205-209. (Pubitemid 36829647)
21. Noisakran S, Halford WP, Veress L, Carr DJ. Role of the hypothalamic pituitary adrenal axis and IL-6 in stress-induced reactivation of latent herpes simplex virus type 1. J Immunol 1998;160:5441-5447. (Pubitemid 28267835)
22. Amelio AL, McAnany PK, Bloom DC. A chromatin insulatorlike element in the herpes simplex virus type 1 latencyassociated transcript region binds CCCTC-binding factor and displays enhancer-blocking and silencing activities. J Virol 2006;80:2358-2368.
23. Bedadala GR, Pinnoji RC, Hsia SC. Early growth response gene 1 (Egr-1) regulates HSV-1 ICP4 and ICP22 gene expression. Cell Res 2007;17:1-10.
24. Chen Q, Lin L, Smith S, et al. A CTCF-dependent chromatin boundary element exists between the LAT and ICP0 promoters in the HSV-1 genome. J Virol J VirolJan 31. doi: 10.1128/JVI.0244-06
25. Kubat NJ, Amelio AL, Giordani NV, Bloom DC. The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr is hyperacetylated during latency independently of L AT transcription. J Virol 2004;78:12508-12518. (Pubitemid 39458769)
26. Kubat NJ, Tran RK, McAnany P, Bloom DC. Specifc histone tail modifcation and not DNA methylation is a determinant of herpes simplex virus type 1 latent gene expression. J Virol 2004;78:1139-1149. (Pubitemid 38095824)
27. Pinnoji RC, Bedadala GR, George B, et al. Repressor element-1 silencing transcription factor/neuronal restrictive silencer factor (REST/NRSF) can regulate HSV-1 immediateearly transcription via histone modifcation. Virol J 2007;4:56. (Pubitemid 47030083)
28. Knipe DM, Cliffe A. Chromatin control of herpes simplex virus lytic and latent infection. Nat Rev Microbiol 2008;6:211-221 (Pubitemid 351256316)
29. Deme D, Pommier J, Nunez J. Kinetics of thyroglobulin iodination and of hormone synthesis catalysed by thyroid peroxidase. Role of iodide in the coupling reaction. Eur J Biochem 1976;70:435-440.
30. Papavasiliou SS, Martial JA, Latham KR, Baxter JD. Thyroid hormonelike actions of 3, 3', 5'-L-triiodothyronine nad 3,3'-diiodothyronine. J Clin Invest 1977;60:1230-1239.
31. Lazar MA. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev 1993;14:184-193. (Pubitemid 23118416)
32. Tsai MJ, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1994;63:451-486.
33. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev 2001;81:1097-1142. (Pubitemid 32606667)
34. Hsia SC, Shi YB. Chromatin disruption and histone acetylation in regulation of the human immunodefciency virus type 1 long terminal repeat by thyroid hormone receptor. Mol Cell Biol 2002;22:4043-4052.
35. Hsia SC, Tomita A, Obata K, et al. Role of chromatin disruption and histone acetylation in thyroid hormone receptor action: implications in the regulation of HIV-1 LTR. Histol Histopathol 2003;18:323-331. (Pubitemid 36040471)
36. Huang ZQ, Li J, Sachs LM, Cole PA, Wong J. A role for cofactor-cofactor and cofactor-histone interactions in targeting p300, SWI/SNF and Mediator for transcription. EMBO J 2003;22:2146-2155. (Pubitemid 36565538)
37. Lee KC, Li J, Cole PA, Wong J, Kraus WL. Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators. Mol Endocrinol 2003;17:908-922. (Pubitemid 36539580)
38. Wallberg AE, Yamamura S, Malik S, Spiegelman BM, Roeder RG. Coordination of p300-mediated chromatin remodeling and TRAP/mediator function through coactivator PGC-1-alpha. Mol Cell 2003;12:1137-1149. (Pubitemid 37487924)
39. Kadam S, Emerson BM. Transcriptional specifcity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol Cell 2003;11:377-389. (Pubitemid 36293832)
40. Yoshinaga SK, Peterson CL, Herskowitz I, Yamamoto KR. Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science 1992;258:1598-1604 (Pubitemid 23012434)
41. Wang S, Zhang B, Faller DV. BRG1/BRM and prohibitin are required for growth suppression by estrogen antagonists. EMBO J 2004;23:2293-2303. (Pubitemid 38833238)
42. Herrera FJ, Triezenberg SJ. VP16-dependent association of chromatin-modifying coactivators and underrepresentation of histones at immediate-early gene promoters during herpes simplex virus infection. J Virol 2004;78:9689-9696.
43. Mador N, Goldenberg D, Cohen O, Panet A, Steiner I. Herpes simplex virus type 1 latency-associated transcripts suppress viral replication and reduce immediate-early gene mRNA levels in a neuronal cell line. J Virol 1998;72:5067-5075. (Pubitemid 28215687)
44. Garber DA, Schaffer PA, Knipe DM. A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1. J Virol 1997;71:5885-5893.
45. Giordani NV, Neumann DM, Kwiatkowski DL, et al. During Hsv-1 infection of Rabbits, the ability to express the lat increases latent-phase transcription of lytic genes. J Virol 2008;82:6056-6060.
46. Awad TA, Bigler J, Ulmer JE, et al. Negative transcriptional regulation mediated by thyroid hormone response element 144 requires binding of the multivalent factor CTCF to a novel target DNA sequence. J Biol Chem 1999;274:27092-27098 (Pubitemid 129520234)
47. Burke LJ, Zhang R, Lutz M, Renkawitz R. The thyroid hormone receptor and the insulator protein CTCF: two different factors with overlapping functions. J Steroid Biochem Mol Biol 2002;83:49-57. (Pubitemid 37040641)
48. Lutz M, Burke LJ, LeFevre P, et al. Thyroid hormone-regulated enhancer blocking: cooperation of CTCF and thyroid hormone receptor. EMBO J 2003;22:1579-1587. (Pubitemid 36417406)
49. Nichol PF, Chang JY, Johnson EM Jr, Olivo PD. Herpes simplex virus gene expression in neurons: viral DNA synthesis is a critical regulatory event in the branch point between the lytic and latent pathways. J Virol 1996;70:5476-5486.
50. Tal-Singer R, Peng C, Ponce de Leon M, et al. Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J Virol 1995;69:4471-4483.
51. Kosz-Vnenchak M, Jacobson J, Coen DM, Knipe DM. Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons. J Virol 1993;67:5383-5393. (Pubitemid 23241372)
52. Hsia SC, Wang H, Shi YB. Involvement of chromatin and histone acetylation in the regulation of HIV-LTR by thyroid hormone receptor. Cell Res 2001;11:8-16. (Pubitemid 33677177)